Standard Nuclear (STDN) Analysts See +65% Upside to $17 Target

Key Takeaways

• The central target of $17 is the arithmetic mean of eight verified analyst price targets, which range from a low of $13 to a high of $20.
• Following a sharp post-earnings decline, shares traded near $10.30, implying roughly 65% upside to the $17 target — a very large move.
• All eight covering analysts rate the stock Buy, Outperform, or Overweight, with no Hold or Sell ratings, supporting a "Strong Buy" consensus.
• The strongest supporting factors are Standard Nuclear's position as the only independent U.S. commercial-scale TRISO fuel fabricator, a backlog that more than doubled to $577.2 million, and delivery of its first complete commercial reactor core.
• The biggest risks are a sharp gross-margin reset, an operating-authorization delay pushed into February 2027, and the timing of converting backlog into revenue.

What the Analyst Consensus Shows

Standard Nuclear, Inc. (STDN) is an Oak Ridge, Tennessee-based developer and manufacturer of TRISO (tri-structural isotropic) nuclear fuel — a coated-particle fuel designed for advanced and small modular reactors. It listed on the NYSE through an initial public offering in July 2026.

The $17 central target reflects eight individual analyst price targets verified across current coverage: UBS at $20, Goldman Sachs at $18, Needham at $18, Stifel at $17, Barclays at $17, Evercore ISI at $17, Bank of America at $15, and RBC Capital at $13. Their arithmetic mean is $16.88, rounded to $17, with an approximate range of $13 to $20. No Hold or Sell ratings appear among the firms publishing targets, though the spread is wide, reflecting genuine disagreement over timing and execution. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Revisions have tilted higher. UBS lifted its target to $20 from $14, Stifel to $17 from $16, and RBC Capital to $13 from $11. Needham initiated coverage with a Buy and an $18 target, citing the company's status as the only merchant TRISO fuel fabricator shipping commercial fuel, while Goldman Sachs initiated with a Buy and $18 target on its positioning for nuclear power deployment. The more cautious $13 target reflects concern that near-term profitability and capacity authorization may take longer to materialize.

Current Position After Earnings

Standard Nuclear reported third-quarter 2026 results on November 12, 2026, and the stock fell roughly 17%, from a prior close of $12.48 to about $10.30. The company posted a net loss of $0.10 per diluted share on revenue of roughly $6.0 million, up sharply from about $0.9 million a year earlier. Total contract backlog reached $577.2 million, up from $241.5 million at the end of June, and funded backlog nearly doubled to $119.6 million.

Reaching $17 from roughly $10.30 would require a gain of about 65%, a very large move that would leave shares just below their 52-week high of $17.34 set in early September. The company completed delivery of Radiant's Kaleidos core — the first complete commercial TRISO reactor core from an independent U.S. manufacturer — and the Department of Energy approved the Kaleidos safety analysis for full-power operation. However, management shifted the authorization target for its Tennessee and Idaho facilities from the fourth quarter of 2026 to February 2027, pushing the revenue inflection further out.

Factors Supporting the Target

• Standard Nuclear is the only independent U.S. manufacturer of TRISO fuel, a structural advantage as advanced reactor developers scale up.
• Total contract backlog more than doubled sequentially to $577.2 million, with funded backlog nearly doubling to $119.6 million.
• Delivery of the first complete commercial reactor core and the DOE safety approval for the Kaleidos reactor validate the commercial pathway.
• An NRC rule finalized in October and an ARPA-E award of roughly $7 million for recycled transuranic TRISO fuel add regulatory and funding support.
• All eight covering analysts maintain Buy-equivalent ratings, with several raising price targets in recent months.

Risks to Consider

• GAAP gross margin fell to 30% from 67% in the second quarter as engineering and payroll costs tied to finishing the Radiant core rose, and management cautioned that neither quarter reflects the run-rate.
• The operating authorization for its facilities slipped to February 2027, delaying the target of 2.5 MTU (metric tons of uranium) per year of installed throughput.
• Net loss widened to $13.1 million from $3.4 million sequentially, and share-based compensation remains elevated.
• A large portion of the backlog — about $443.5 million — consists of purchase options at customer discretion, making conversion to revenue uncertain.
• At a roughly $1.9 billion market capitalization with minimal current revenue, the valuation leaves little room for execution missteps.

Technical Levels and Market Structure

STDN's 52-week range is $7.05 to $17.34. The $17.34 high set in early September serves as the nearest meaningful resistance level, meaning the $17 target sits just beneath that prior peak. On the downside, the July low of $7.05 marks the key long-term support level, with the recent trading band around $10.30 to $12.48 representing an intermediate zone where buyers have stepped in after sharp selloffs.

What to Watch Going Forward

Analyst price targets generally reflect a roughly 12-month research horizon, though individual firms vary. Investors should watch the February 2027 facility authorization, the conversion of purchase options into funded backlog, quarterly gross-margin trends, and the next earnings report. Any additional analyst revisions — particularly if firms adjust targets to reflect the post-earnings margin reset — could shift the consensus. Regulatory decisions from the DOE and NRC and new fuel supply agreements will also matter. From what I see, these milestones will determine whether the stock can sustain momentum.

Using AI Daily Buy/Sell Signals in My Process

For a data-driven complement to fundamental analysis, I often review AI Daily Buy/Sell Signals from Tickeron. This tool uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. It helps me discover new opportunities, monitor existing positions, and spot shifting trends more efficiently. I find it particularly useful when evaluating names like STDN after volatile moves.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Contributor

Sergey Savastiouk|Expert

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.

Notable companies

Industry description

Market Cap

High and low price notable news

Volume